Holen Sie sich die Stockscreener-App
15.62
2.25%
-0.36
Vorhandelsmarkt:
15.75
0.13
+0.83%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.98
Offen:
$15.86
24-Stunden-Volumen:
2.00M
Relative Volume:
0.62
Marktkapitalisierung:
$3.11B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-7.5459
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+0.97%
1M Leistung:
+10.94%
6M Leistung:
-21.19%
1J Leistung:
-44.23%
1-Tages-Spanne:
$15.45
$15.95
1-Wochen-Bereich:
$15.45
$16.70
52-Wochen-Spanne:
$12.16
$28.25
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
15.62 | 3.26B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
553.29 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.40 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.17 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.03 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.55 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Removable Partial Denture Market Insights and Forecast from - openPR.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Dentsply Sirona Appoints Matthew E. Garth as CFO - Orthodontic Products
Earnings Estimates Moving Higher for Dentsply (XRAY): Time to Buy? - Yahoo Finance
Dentsply Sirona has a new CFO - MassDevice
Are Investors Undervaluing Dentsply Sirona (XRAY) Right Now? - sharewise
DENTSPLY SIRONA (NASDAQ:XRAY) Will Pay A Dividend Of $0.16 - simplywall.st
Dentsply Sirona appoints Matthew E. Garth as CFO - MSN
Clear Aligners Market Surging with Digital Orthodontics - openPR.com
Removable Partial Denture Market Is Booming So Rapidly 2025-2032Dentsply Sirona, Ivoclar Vivadent, Straumann - openPR.com
DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16 - Yahoo
Dentsply Sirona (XRAY) Names Matthew E. Garth as New CFO - GuruFocus
Dentsply Sirona Appoints Matthew E. Garth As Chief Financial Officer - marketscreener.com
Dentsply Sirona Appoints New CFO Matthew E. Garth - TipRanks
Dentsply Sirona names Matthew Garth as new CFO - Investing.com
Dentsply Sirona Names Matthew Garth CFO - marketscreener.com
Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer | XRAY Stock News - GuruFocus
Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer - GlobeNewswire
Dentsply Sirona Taps 30-Year Finance Veteran from ScottsMiracle-Gro to Lead Financial Transformation - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect - ACCESS Newswire
Dental Devices Market Set to Witness Significant GrowthDentsply Sirona, Straumann - openPR.com
3D Printed Dentures Market Emerging Trends and Growth Prospects 2034 | Stratasys, D Systems , Dentsply Sirona - openPR.com
Dentsply Sirona at Stifel Jaws & Paws Conference: Strategic Growth Amid Challenges - Investing.com Australia
Transcript : DENTSPLY SIRONA Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 09 - marketscreener.com
Dental Cameras Market Is Booming WorldwideCarestream Dental, Dentsply Sirona - openPR.com
Dentsply Sirona Declares Quarterly Cash Dividend | XRAY Stock Ne - GuruFocus
Dentsply Sirona Declares Quarterly Cash Dividend | XRAY Stock News - GuruFocus
Dentsply Sirona Declares Quarterly Cash Dividend - The Manila Times
Dentsply Sirona Keeps Quarterly Dividend at $0.16 a Share, Payable July 11 to Shareholders of Record on June 27 - marketscreener.com
DENTSPLY SIRONA Inc. Declares Quarterly Cash Dividend of $0.16 Per Share - Nasdaq
Dentsply Sirona Declares Quarterly Cash Dividend - Benzinga
Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know - Yahoo Finance
Dental Veneers Market Projected to Witness Massive GrowthDentsply Sirona, Ivoclar Vivadent - openPR.com
Dental Biomaterials Market Projected to Witness Massive Growth3M, Dentsply Sirona - openPR.com
Saudi Arabia Dental Implants Market Trends and Forecasts 2020-2024 & 2025-2030, Competitive Analysis of Masar Medical, Keydent, Zimmer Biomet, Dentsply Sirona, and Henry Schein - Yahoo
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Cetera Investment Advisers - Defense World
Dental Anesthetics Market worth US$1.80 billion by 2030 with 4.0% CAGR | MarketsandMarkets™. - GlobeNewswire
Dental Implants Market Projected to Reach $8.63 Billion by 2034 – BIS Research - industrytoday.co.uk
From scan to smile: Enhancing patient care through digital innovation - Dental Tribune US
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
A Comparative Evaluation of Post-operative Pain in Patients Undergoing Root Canal Treatment With Four Different Types of Sealers: A Randomized Controlled Trial - Cureus
DENTSPLY SIRONA reports annual meeting results By Investing.com - Investing.com Nigeria
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages DENTSPLY SIRONA Inc. (XRAY) Investors with Over $1 Million Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
DENTSPLY SIRONA reports annual meeting results - Investing.com
DENTSPLY SIRONA Holds Annual Stockholder Meeting - TipRanks
Digital Denture Market Set to Witness Significant Growth by 2025-2032 | Dentsply Sirona Inc., Straumann Group - openPR.com
Global Dental Implants And Prosthesis Market to grow at a CAGR - openPR.com
Global Dental Implants And Prosthesis Market to grow at a CAGR of 7.79% by 2030, Evaluates DelveInsight | Danaher Corporation, Straumann Holding AG, Dentsply Sirona, Zimmer Biomet, BioHorizons - The Globe and Mail
High Point University partners with NC manufacturer to supply new dental school - The Business Journals
Orthodontic Supplies Market Generated Opportunities, Future - openPR.com
Dental Anesthetics Market Dental Anesthetics | Septodont, Dentsply Sirona, 3M Company - openPR.com
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):